Latest Updates: State And Federal Abortion Policies Impacting Reproductive Medicine
As state and federal lawmakers act to reform policies following the Supreme Court’s Dobbs decision, related litigation is also ongoing. Get the latest updates here.
On Wednesday, August 16, a federal appeals court said the FDA overstepped its authority when it made the drug more accessible and ruled to limit access to the abortion pill. The ruling from a three-judge panel of the New Orleans-based 5th US Circuit Court of Appeals is not expected to immediately affect access to mifepristone. For now, an earlier US Supreme Court decision pausing any changes to the status quo stands, with an appeal of the federal court’s ruling to the highest court expected in short order.